Who owns Tango Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TNGX from SEC Form 13F filings across 258 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 258 institutions disclosed 213.5M shares of Tango Therapeutics, Inc. worth $5.28B — about 122.8% of shares outstanding; the largest disclosed holder is RTW INVESTMENTS, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
258
13F holders
$5.28B
value, 2026 filers
122.8%
of shares outstanding (213.5M sh)
48
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TNGX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RTW INVESTMENTS, LP | 14.0M | $350.5M | 3.5% | 8.1% | +1.1% |
| 2 | FMR LLC | 13.1M | $328.0M | 0.0% | 7.6% | +6.6% |
| 3 | BlackRock, Inc. | 13.1M | $327.9M | 0.0% | 7.6% | +5.7% |
| 4 | GOLDMAN SACHS GROUP INC | 11.4M | $284.7M | 0.0% | 6.6% | +14.3% |
| 5 | Boxer Capital Management, LLC | 10.5M | $262.6M | 22.8% | 6.1% | -3.2% |
| 6 | STATE STREET CORP | 7.3M | $182.5M | 0.0% | 4.2% | +22.3% |
| 7 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 7.3M | $181.1M | 0.3% | 4.2% | +29.6% |
| 8 | Paradigm Biocapital Advisors LP | 7.0M | $173.7M | 3.5% | 4% | +9.5% |
| 9 | Siren, L.L.C. | 6.8M | $169.3M | 4.0% | 3.9% | +9.8% |
| 10 | TCG Crossover Management, LLC | 6.8M | $169.0M | 4.8% | 3.9% | -25.4% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 6.5M | $162.6M | 0.0% | 3.7% | +9.4% |
| 12 | PRICE T ROWE ASSOCIATES INC /MD/ | 6.4M | $158.7M | 0.0% | 3.7% | +0.2% |
| 13 | DEERFIELD MANAGEMENT COMPANY, L.P. | 5.2M | $129.2M | 2.0% | 3% | +23.6% |
| 14 | Janus Henderson Group Ltd.NEW | 4.9M | $123.3M | 0.1% | 2.8% | new |
| 15 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 4.6M | $113.5M | 0.5% | 2.6% | -62.9% |
| 16 | Deep Track Capital, LP | 4.5M | $112.3M | 1.8% | 2.6% | +7.1% |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 4.0M | $100.8M | 0.0% | 2.3% | +7.9% |
| 18 | Woodline Partners LP | 4.0M | $99.8M | 0.3% | 2.3% | 0.0% |
| 19 | Holocene Advisors, LP | 3.5M | $86.4M | 0.2% | 2% | +43.7% |
| 20 | Polar Capital Holdings Plc | 3.5M | $86.4M | 0.2% | 2% | +133.8% |
| 21 | ORBIMED ADVISORS LLCNEW | 2.8M | $69.3M | 1.3% | 1.6% | new |
| 22 | PERCEPTIVE ADVISORS LLC | 2.7M | $67.2M | 1.2% | 1.5% | -20.3% |
| 23 | Caligan Partners LP | 2.5M | $62.4M | 3.8% | 1.4% | 0.0% |
| 24 | FRANKLIN TEMPLETON INC | 2.4M | $54.7M | 0.0% | 1.4% | +25.0% |
| 25 | Seven Fleet Capital Management LP | 2.2M | $55.7M | 10.9% | 1.3% | -30.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.